Clinical trials: Obstetric Bleeding
Postpartum Hemorrhage
Study of Biological Determinants of Bleeding Postpartum
At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices.
- Trial name
- HPP-IPF (NCT02884804)
- Where
- France
- Volunteers
- 3,599 people
- Sponsor
- University Hospital, Brest
Postpartum Haemorrhage
World Maternal Antifibrinolytic Trial
The WOMAN trial is a large pragmatic randomised double-blind, placebo controlled trial to quantify the effects of the early administration of tranexamic acid on death, hysterectomy and other relevant outcomes.
- Trial name
- WOMAN (NCT00872469)
- Testing
- Tranexamic acid
- Where
- Nigeria
- Volunteers
- 20,060 people
- Sponsor
- London School of Hygiene and Tropical Medicine
Postpartum Hemorrhage (PPH), Placental Dysfunction
Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta
This retrospective, monocentric study aims to examine risk factors for postpartum hemorrhage in women with histologically verified placenta accreta.
- Trial name
- NCT05542043
- Testing
- Data collection
- Where
- Switzerland
- Volunteers
- 2,348 people
- Sponsor
- University Hospital, Basel, Switzerland
Post Partum Hemorrhage
Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery
Bleeding is still the major cause of mortality and morbidity in postpartum period. World health organization has reported 585000 deaths for pregnancy each year. Twenty five percent of cases die from post-partum bleeding.
- Trial name
- NCT03148574
- Testing
- Misoprostol, Oxytocin
- Where
- Egypt
- Volunteers
- 240 people
- Sponsor
- Assiut University
Placenta Previa Without Hemorrhage
Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa
This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.
- Trial name
- NCT02002026
- Testing
- Uterine artery ligation
- Where
- Egypt
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- Minia Maternity University Hospital
Management of Delivery
Effectiveness of Placental Drainage in the Third Stage of Labor: a Randomized Clinical Trial
The purpose of this study is to determine if placental drainage shortens third period of labor and reduces postpartum blood lost.
- Trial name
- PLADRAINAGE (NCT01655576)
- Testing
- Placental drainage
- Where
- Brazil
- Volunteers
- 226 people, healthy volunteers welcome
- Sponsor
- Instituto Materno Infantil Prof. Fernando Figueira
Effectiveness of Chitosan Covered Gauze to Stop Bleeding in Post-partum Tears, Comparison of the Effect of Chitosan Covered Gauze With Suturing in Terms of Hemostasis in Post-partum Haemorrhagic Tears
EFFECTIVITY OF CHITOSAN COVERED GAUZE IN POSTPARTUM HEMORRHAGIC OBSTETRIC LACERATIONS
This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period.
- Trial name
- NCT06998641
- Testing
- Chitosan-covered-gauze application, Suturation
- Where
- Turkey (Türkiye)
- Volunteers
- 62 people
- Sponsor
- Istanbul Training and Research Hospital
Postpartum Hemorrhage, High Risk Pregnancy
Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women
Postpartum hemorrhage and its complications are very well known causes for maternal mortality .Uterine atony is the most common cause for postpartum hemorrhage
- Conditions
- Postpartum Hemorrhage, High Risk Pregnancy, Tranexamic Acid, Third-Stage Postpartum Hemorrhage, With Delivery
- Trial name
- NCT04201951
- Testing
- Tranexamic acid injection, Glucose water 5%
- Where
- 2 sites in Iraq
- Volunteers
- 196 people
- Sponsor
- Hawler Medical University
Postpartum Hemorrhage
rhuFVIIa in Post-partum Hemorrhage
The aim of this clinical research project is to evaluate the use of the recombinant human activated factor VII (rhFVIIa), given as a salvage therapy, in women with a dramatic postpartum hemorrhage still ongoing after all the…
- Trial name
- NCT00370877
- Testing
- rFVIIa, Standard Care
- Where
- 8 sites in France, Switzerland
- Volunteers
- 84 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Post Partum Haemorrhage
Improving Management of Post-partum Haemorrhage With Quantra® System
Post partum haemorrhage is a concerning situation in maternity wards, though it is not the first cause of maternal mortality anymore.
- Trial name
- Quantralab (NCT05336838)
- Volunteers
- 60 people
- Sponsor
- University Hospital, Montpellier
Premature Birth, Respiratory Distress Syndrome in Premature Infant
Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns
Before birth, the baby's lungs are filled with fluid and babies do not use the lungs to breathe, as the oxygen comes from the placenta. As delivery approaches, the lungs begin to absorb the fluid.
- Conditions
- Premature Birth, Respiratory Distress Syndrome in Premature Infant, Sepsis, Intraventricular Hemorrhage of Prematurity
- Trial name
- PhyCordPrem (NCT06280872)
- Testing
- Physiological Based Cord Clamping, Differed Cord Clamping
- Where
- 2 sites in Belgium
- Volunteers
- 180 people
- Sponsor
- Queen Fabiola Children's University Hospital
Post Partum Hemorrhage
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
The overall aim of this project is to include currently available information from women with severe postpartum haemorrhage (sPPH) who were treated with NovoSeven® and to examine whether NovoSeven® may have affected the course of…
- Trial name
- NCT04723979
- Testing
- Eptacog alfa, Standard of care
- Where
- Netherlands
- Volunteers
- 3,322 people
- Sponsor
- Leiden University Medical Center
Post Partum Hemorrhage
Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone
While Carbetocin is effective in reducing PPH, the combination of oxytocin, Tranexamic acid, and Ergot derivatives may offer additional benefits in high-risk populations.
- Trial name
- NCT07318467
- Testing
- Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative, Intravenous Carbetocin alone
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Cairo University
Postpartum Hemorrhage
In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine
Postpartum hemorrhage (PPH) remains to be one of the leading causes of maternal morbidity and mortality. It has been noted that an increasing number of PPH is attributed to the increased incidence of uterine atony.
- Trial name
- NCT05511415
- Testing
- Oxytocin, Dexmedetomidine
- Where
- Canada
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Puerperal Sepsis, Postpartum Hemorrhage
Assessing Childbirth-related Complications at the Community Level in Kenya
Kenya is one of the countries in sub-Saharan Africa that still experience high maternal mortality. For instance, in 2008/09 maternal mortality ratio was estimated to be 488/100,000 live births.
- Conditions
- Puerperal Sepsis, Postpartum Hemorrhage, Preeclampsia and Eclampsia, Retained Placenta, Without Hemorrhage
- Trial name
- NCT01665456
- Where
- Kenya
- Volunteers
- 585 people, healthy volunteers welcome
- Sponsor
- Wilson Liambila
Postpartum Hemorrhage, Anemia
Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or…
- Trial name
- NCT00120237
- Testing
- Misoprostol
- Where
- Pakistan
- Volunteers
- 1,600 people, healthy volunteers welcome
- Sponsor
- Gynuity Health Projects
Postpartum Haemorrhage
Carbetocin Versus Syntometrine for the Third Stage of Labour
Intramuscular carbetocin is as effective as intramuscular syntometrine for the prevention of postpartum haemorrhage
- Trial name
- NCT00499005
- Testing
- Syntommetrine and Carbetocin
- Where
- Singapore
- Volunteers
- 720 people, healthy volunteers welcome
- Sponsor
- National University Hospital, Singapore
Postpartum Hemorrhage
Controlled Cord Traction During Third Stage of Labor
Of the estimated number of 529,000 maternal deaths for the year 2000, 132,000 (25%) were caused by postpartum hemorrhage (PPH); 99% of these deaths occurred in low-income countries.
- Trial name
- CCT (NCT00781066)
- Testing
- Controlled cord traction, No controlled cord traction
- Where
- 2 sites in Uruguay
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Universidad de la Republica
Hemorrhage Postpartum, Fertility Disorders
Fertility After Intrauterine Tamponing Balloon: Where Are we
Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB).
- Trial name
- FERTIBTIU (NCT04133402)
- Where
- France
- Volunteers
- 59 people
- Sponsor
- University Hospital, Lille
Health Care Cost, Post Partum Haemorrhage
Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy
The main objective of this project is to assess the average cost of the treatment of bleeding postpartum with recombinant activated factor VII (NovoSeven®) and compare it to the reference strategy.
- Trial name
- NCT02900690
- Where
- France
- Volunteers
- 84 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes